Drug intelligence / Profile preview

ESK440

Development stage
Preclinical
Lead developer
University of Michigan
01

Overview

ESK440: sourced facts only. name: "Given the potential roles of ALK and FAK in NB, we evaluated the efficacy of a novel compound ESK440, which is a dual ALK and FAK inhibitor." [DOI:10.1158/1538-7445.am2022-2018]; target: "Given the potential roles of ALK and FAK in NB, we evaluated the efficacy of a novel compound ESK440, which is a dual ALK and FAK inhibitor." [DOI:10.1158/1538-7445.am2022-2018]; target: "Given the potential roles of ALK and FAK in NB, we evaluated the efficacy of a novel compound ESK440, which is a dual ALK and FAK inhibitor." [DOI:10.1158/1538-7445.am2022-2018]; developer: "1University of Michigan, Ann Arbor, MI." [DOI:10.1158/1538-7445.am2022-2018]; stage: "Intriguingly, ESK440 studies in NB xenograft model (NB-1) resulted in tumor regression in treated animals." [DOI:10.1158/1538-7445.am2022-2018]

02

Targets

ALK (Anaplastic lymphoma kinase receptor tyrosine kinase)FAK (Focal adhesion kinase)

Beyond the preview

Go deeper on ESK440.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ESK440.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call